Bispecific Antibody Effective in Untreated Follicular Lymphoma

By News Health
3 months Ago

(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for patients with previously untreated follicular lymphoma with a high tumor burden.
In this MedPage Today…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearls/119131

Author :

Publish date : 2025-12-22 17:08:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cardiology Group to Pay Nearly $5 Million for Alleged Vein Ablation Fraud

U.S. Flu Season Winding Down

Low Testosterone May Raise Risk of 'Extreme' Prostate Cancer Progression

New U.S. Lipid Guideline Redefines Risk Categories, Boosts Non-Cholesterol Tests

Reclassification From Type 2 to Type 1 Diabetes Not Uncommon

COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?